- Home
- MRCC vs CBUS Comparison
MRCC vs CBUS Comparison
Compare MRCC & CBUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRCC
- CBUS
- Stock Information
- Founded
- MRCC 2011
- CBUS 2010
- Country
- MRCC United States
- CBUS United States
- Employees
- MRCC N/A
- CBUS N/A
- Industry
- MRCC Investment Managers
- CBUS Agricultural Chemicals
- Sector
- MRCC Finance
- CBUS Industrials
- Exchange
- MRCC Nasdaq
- CBUS Nasdaq
- Market Cap
- MRCC 174.8M
- CBUS 160.8M
- IPO Year
- MRCC 2012
- CBUS 2017
- Fundamental
- Price
- MRCC $7.81
- CBUS $3.88
- Analyst Decision
- MRCC Strong Buy
- CBUS Strong Buy
- Analyst Count
- MRCC 1
- CBUS 3
- Target Price
- MRCC $9.00
- CBUS $23.33
- AVG Volume (30 Days)
- MRCC 47.0K
- CBUS 276.6K
- Earning Date
- MRCC 11-06-2024
- CBUS 11-07-2024
- Dividend Yield
- MRCC 12.58%
- CBUS N/A
- EPS Growth
- MRCC 194.63
- CBUS N/A
- EPS
- MRCC 0.36
- CBUS N/A
- Revenue
- MRCC $61,955,000.00
- CBUS $2,961,000.00
- Revenue This Year
- MRCC N/A
- CBUS $36.93
- Revenue Next Year
- MRCC N/A
- CBUS $236.45
- P/E Ratio
- MRCC $22.08
- CBUS N/A
- Revenue Growth
- MRCC N/A
- CBUS 816.72
- 52 Week Low
- MRCC $6.69
- CBUS $3.58
- 52 Week High
- MRCC $8.14
- CBUS $23.18
- Technical
- Relative Strength Index (RSI)
- MRCC 48.35
- CBUS 30.27
- Support Level
- MRCC $7.73
- CBUS $3.58
- Resistance Level
- MRCC $8.11
- CBUS $5.58
- Average True Range (ATR)
- MRCC 0.16
- CBUS 0.62
- MACD
- MRCC -0.02
- CBUS -0.07
- Stochastic Oscillator
- MRCC 19.51
- CBUS 8.31
About MRCC Monroe Capital Corporation
Monroe Capital Corp is a speciality finance company focused on providing financing to lower middle-market companies, in the U.S. and Canada. The company provides customized financing solutions focused on senior, unitranche, and junior secured debt and unsecured subordinated debt and equity, including equity co-investments in preferred and common stock and warrants.
About CBUS Cibus Inc.
Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.